Tr1x
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $63M
Investors
- 3
About Tr1x
Based in California, US, and founded in 2018 by Professor Maria Grazia Roncarolo, Tr1x Inc. operates as a biotechnology company focused on engineering cures for autoimmune and inflammatory diseases. In January 2024, Tr1x, Inc. Tr1x Inc. is engaged in the development of cellular therapies with the potential to cure disease by inducing immune tolerance and restoring homeostasis through the engineering of T cells. Tr1x Inc. has a state-of-the-art technology platform that allows for the scalable generation of engineered living drugs to help patients suffering from debilitating diseases with high unmet medical needs.
Who invested in Tr1x
3 investors across 2 rounds
See all investors in Tr1x
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tr1x
Who invested in Tr1x?
Tr1x has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tr1x raised?
Tr1x has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tr1x last raise money?
Tr1x's most recent round on record is a Series A, in Dec 2023.
What does Tr1x do?
Based in California, US, and founded in 2018 by Professor Maria Grazia Roncarolo, Tr1x Inc.
Where is Tr1x headquartered?
Tr1x is headquartered in San Diego, US.
Which VCs invest in companies like Tr1x?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tr1x's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tr1x? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.